alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Justice

###### Antitrust Division

      ( print page 10066)    
                    Notice is hereby given that, on January 8, 2008, pursuant to section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301*et seq.*                     (“the Act”), PXI Systems Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. Specifically, Advantech, Shing-Tien City, Taipei, Taiwan; United Electronic Industries, Inc., Walpole, MA; ELMA Electronic Inc., Fremont, CA; Corelis, Cerritos, CA; Advanced Integration LLC, Columbus, OH; Mindready Solutions, Inc., Saint-Laurent, Quebec, Canada; Digalog Systems, Inc., New Berlin, WI; PLDA, Inc., Aix-en—Provence Cedex, France; and Signametrics, Seattle, WA have withdrawn as parties to this venture.                

No other changes have been made in either the membership or planned activity of the group research project. Membership in this group research project remains open, and PXI Systems Alliance, Inc. intends to file additional written notifications disclosing all changes in membership.

                    On November 22, 2000, PXI Systems Alliance, Inc. filed its original notification pursuant to section 6(a) of the Act. The Department of Justice published a notice in the                     **Federal Register**                     pursuant to section 6(b) of the Act on March 8, 2001 (66 FR 13971).                

                    The last notification was filed with the Department on October 29, 2007. A notice was published in the                     **Federal Register**                     pursuant to section 6(b) of the Act on December 20, 2007 (72 FR 72388).                

Patricia A. Brink,

Deputy Director of Operations, Antitrust Division.

[FR Doc. 08-804  Filed 2-22-08; 8:45 am]

BILLING CODE 4410-11-M
1 

AGENDA 

Advisory Board on Radiation and Worker Health – Meeting 114 

Hilton Santa Fe Historic Plaza

100 Sandoval Street, Santa Fe, New Mexico 87501

Phone: (505) 986-6416; Fax: (505) 986-6439. 

Teleconference Phone: 866-659-0537, Participant Code: 9933701# 

LiveMeeting Link: https://www.livemeeting.com/cc/cdc/join?id= Z9K2DF

&role=attend&pw=ABRWH

Meeting ID: Z9K2DF Entry Code: ABRWH

Wednesday, November 30, 2016 

NOTE: All times in Mountain Time 

8:15 a.m. – 8:30 a.m. Welcome and Introduction Dr. James Melius, Chair

8:30 a.m. – 8:45 a.m. NIOSH Program Update Mr. Stuart Hinnefeld, NIOSH 

8:45 a.m. – 9:00 a.m. DOL Program Update Mr. Jeff Kotsch, DOL 

9:00 a.m. – 9:15 a.m. DOE Program Update Mr. Greg Lewis, DOE

9:15 a.m. – 10:00 a.m. Review of Hooker

Electrochemical Site Profile

Dr. Henry Anderson 

WG Chair

10:00 a.m. – 10:15 a.m. Break

10:15 a.m. – 11:45 p.m. Carborundum Company SEC 

petition (1943-1976, Niagara 

Falls, NY) 

Dr. Genevieve Roessler, WG 

Chair

Petitioners:

11:45 a.m. – 12:30 p.m. Board Work Session Dr. James Melius, Chair

12:30 p.m. – 2:00 p.m. Lunch

2:00 p.m. – 2:15 p.m. SEC Petitions Status Update Mr. LaVon Rutherford, 

NIOSH

2:15 p.m. – 2:45 p.m. Savannah River Site SEC 

Petition Update

Mr. Stuart Hinnefeld, NIOSH

Mr. Joe Fitzgerald, SC&A
2 

2:45 p.m. – 3:00 p.m. Dose Reconstruction Report to 

the Secretary

Dr. James Melius, Chair

3:00 p.m. –4:00 p.m. Board Work Session Dr. James Melius, Chair

4:00 p.m. – 4:30 p.m. Break

4:30 p.m. – 5:00 p.m. Los Alamos National 

Laboratory SEC Petition 

Update 

Mr. LaVon Rutherford, 

NIOSH

Petitioner: 

5:00 p.m. – 6:00 p.m.* Public Comment

6:00 p.m. Adjourn, Day 1

* Public comment period will conclude at 6:00 p.m. or following the final call for public comment, 

whichever comes first. If you plan to comment, please be prepared to comment at 5:00 p.m. 

Thursday, December 1, 2016 

NOTE: All times in Mountain Time

8:15 a.m. – 8:30 a.m. Welcome and Introduction Dr. James Melius, Chair

8:30 a.m. – 10:00 a.m. Santa Susanna Field 

Laboratory SEC Petition 234 

(1965 - 1988 , Ventura 

County, CA) 

Dr. Lara Hughes, NIOSH

Mr. Phil Schofield, WG Chair 

Petitioners: 

10:00 a.m. Adjourn
Division of Compensation Analysis and 

Support

Program Evaluation Report

Document Number: DCAS-PER-050

Effective Date: 3/13/2014

Revision No. 0

Bliss and Laughlin Appendix Page 1 of 2

Author: Signature on file Date: 3/13/2014 _ 

 Dave Allen, HP Team Leader

Approval: Signature on file Date: 3/13/2014 _ 

 J.W. Neton, Associate Director for Science

Supersedes: None

RECORD OF ISSUE/REVISIONS

ISSUE 

AUTHORIZATION 

DATE

3/13/2014

EFFECTIVE 

DATE

3/13/2014

REV. NO. 

0

DESCRIPTION

New document to determine the effect 

on previously completed claims due to 

the approval of the Bliss and Laughlin 

Appendix.

1.0 Description

Bliss and Laughlin dose estimates are currently completed using Appendix D of BattelleTBD-6000 which was issued on 9/11/2012. Prior to the issuance of Appendix D, claims 

were completed using Battelle-TBD-6000 without site specific guidance. Prior to that, 

ORAUT-OTIB-0004 was used to complete these claims. During research conducted in 

response to a Special Exposure Cohort (SEC) petition, additional information was found 

that allowed a site specific dose reconstruction method to be developed. The method was 

reviewed by the Advisory Board during deliberation of the SEC. The Secretary of Health 

and Human Services determined an SEC class would not be added for this site and 

Appendix D was later formalized and approved based on the developed method.

Also, during that time frame, the covered employment period for Bliss and Laughlin 

changed from starting in 1948 to starting in 1951.

2.0 Issue Evaluation

Appendix D provides a dose estimate for Bliss and Laughlin claims that is lower in most 

respects than either ORAUT-OTIB-0004 or Battelle-TBD-6000. However, the appendix 

does not categorize employees by the type of work they perform while Battelle-TBD6000 does. While many dose estimates would decrease with the approval of the 

appendix, the possibility exists that some may increase depending on the job category 

used for the particular claim.
Division of Compensation Analysis and 

Support

Program Evaluation Plan

Document Number: DCAS-PER-050

Effective Date: 3/14/2014 Revision No. 0 Page 2 of 2

3.0 Plan for Resolution or Corrective Action

A search was performed for all Bliss and Laughlin claims meeting the following criteria:

 Probability of causation less than 50%; and,

 Dose reconstruction completed prior to 9/11/2012, the date the appendix was 

approved.

The search resulted in 27 claims meeting the criteria.

3.1 Determination of claims which will change due to TBD revision.

Dose for the each of the 27 claims was recalculated using all current dose reconstruction 

methods. From the recalculated dose, a new probability of causation (POC) was 

determined. The POC remained below 45% for all 27 claims. NIOSH will provide the 

Department of Labor with the identity of all the claims evaluated under this PER.
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 This is notice that on March 15, 2010, Penick Corporation, 33 Industrial Park Road, Pennsville, New Jersey 08070, made application by renewal to the Drug Enforcement Administration (DEA) for registration as an importer of the basic classes of controlled substances listed in schedule II. Drug
ScheduleCoca Leaves (9040)
IIRaw Opium (9600)
IIPoppy Straw (9650)
IIConcentrate of Poppy Straw (9670)
II
 The company plans to import the listed controlled substances to manufacture bulk controlled substance intermediates for sale to its customers. As explained in the Correction to Notice of Application pertaining to Rhodes Technologies, 72 FR 3417 (2007), comments and requests for hearings on applications to import narcotic raw material are not appropriate. As noted in a previous notice published in the 
                    **Federal Register**
                     on September 23, 1975, (40 FR 43745), all applicants for registration to import a basic class of any controlled substance in schedule I or II are, and will continue to be, required to demonstrate to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, that the requirements for such registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 1301.34(b), (c), (d), (e), and (f) are satisfied. Dated: April 26, 2010. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. 2010-10115 Filed 4-29-10; 8:45 am] BILLING CODE 4410-09-P
Presidential Documents

9437 

Federal Register 

Vol. 73, No. 34 

Wednesday, February 20, 2008 

Title 3— 

The President 

Executive Order 13461 of February 15, 2008 

Providing an Order of Succession Within the Department of 

Health and Human Services 

By the authority vested in me as President by the Constitution and the 

laws of the United States of America, including the Federal Vacancies Reform 

Act of 1998, 5 U.S.C. 3345 et seq., it is hereby ordered that: 

Section 1. Subject to the provisions of section 3 of this order, the officers 

named in section 2, in the order listed, shall act as and perform the functions 

and duties of the Office of the Secretary of Health and Human Services 

(Secretary), if they are eligible to act as Secretary under the provisions 

of the Federal Vacancies Reform Act of 1998, during any period in which 

the Secretary has died, resigned, or become otherwise unable to perform 

the functions and duties of the office of Secretary. 

Sec. 2. Order of Succession. 

(a) Deputy Secretary of Health and Human Services; 

(b) General Counsel of the Department of Health and Human Services; 

(c) Assistant Secretary (Resources and Technology); 

(d) Assistant Secretary (Planning and Evaluation); 

(e) Administrator of the Centers for Medicare and Medicaid Services; 

(f) Commissioner of Food and Drugs; 

(g) Director of the National Institutes of Health; 

(h) Assistant Secretary for Family Support; 

(i) Other Assistant Secretaries of the Department of Health and Human 

Services appointed by the President, in the order in which they shall have 

taken the oath of office as such; 

(j) Director, Centers for Disease Control and Prevention; and 

(k) Director, Region 4. 

Sec. 3. Exceptions. 

(a) No individual who is serving in an office listed in section 2 of this 

order in an acting capacity, by virtue of so serving, shall act as Secretary 

pursuant to this order. 

(b) Notwithstanding the provisions of this order, the President retains discretion, consistent with the Federal Vacancies Reform Act of 1998, to depart 

from this order in designating an acting Secretary. 


rwilkins on PROD1PC63 with NOTICES
9438 Federal Register / Vol. 73, No. 34 / Wednesday, February 20, 2008 / Presidential Documents 

Sec. 4. Revocation. Executive Order 13250 of December 28, 2001 (Providing 

An Order of Succession Within the Department of Health and Human Services), and the President’s memorandum of March 19, 2002 (Designation 

of Officers of the Department of Health and Human Services), are hereby 

revoked. 

THE WHITE HOUSE, 

February 15, 2008. 

[FR Doc. 08–797 

Filed 2–19–08; 8:50 am] 

Billing code 3195–01–P 


rwilkins on PROD1PC63 with NOTICESGWBOLD.EPS</GPH>
# Europeiska unionens L 150/2016

| | ISSN 1977-0820 |
| --- | --- |
| Europeiska unionens
  officiella tidning | L 150 |
| | |
| Svensk utgåva | Lagstiftning | 59 årgången7 juni 2016 |

ISSN 1977-0820

Europeiska unionens

officiella tidning

L 150

Svensk utgåva

Lagstiftning

59 årgången7 juni 2016

---

| Innehållsförteckning | | Rättelser | Sida |
| --- | --- | --- | --- |
| | * | Rättelseprotokoll till Lissabonfördraget om ändring av fördraget om Europeiska unionen och fördraget om upprättandet av Europeiska gemenskapen, undertecknat i Lissabon den 13 december 2007( EUT C 306 av den 17.12.2007 ) | 1 |

Innehållsförteckning

Rättelser

Sida

*

Rättelseprotokoll till Lissabonfördraget om ändring av fördraget om Europeiska unionen och fördraget om upprättandet av Europeiska gemenskapen, undertecknat i Lissabon den 13 december 2007( EUT C 306 av den 17.12.2007 )

( EUT C 306 av den 17.12.2007 )

1

| SV | De rättsakter vilkas titlar är tryckta med fin stil är sådana rättsakter som har avseende på den löpande handläggningen av jordbrukspolitiska frågor. De har normalt en begränsad giltighetstid.
  Beträffande alla övriga rättsakter gäller att titlarna är tryckta med fetstil och föregås av en asterisk. |
| --- | --- |

SV

De rättsakter vilkas titlar är tryckta med fin stil är sådana rättsakter som har avseende på den löpande handläggningen av jordbrukspolitiska frågor. De har normalt en begränsad giltighetstid.

Beträffande alla övriga rättsakter gäller att titlarna är tryckta med fetstil och föregås av en asterisk.

---

Rättelser

| 7.6.2016 | SV | Europeiska unionens officiella tidning | L 150/1 |
| --- | --- | --- | --- |

7.6.2016

SV

Europeiska unionens officiella tidning

L 150/1

---

Rättelseprotokoll till Lissabonfördraget om ändring av fördraget om Europeiska unionen och fördraget om upprättandet av Europeiska gemenskapen, undertecknat i Lissabon den 13 december 2007

(
  Europeiska unionens officiella tidning C 306 av den 17 december 2007
  )

Denna rättelse har genomförts genom ett rättelseprotokoll som undertecknades i Rom den 20 maj 2016 med Republiken Italiens regering som depositarie.

Protokoll, del B (protokoll som fogas till Lissabonfördraget), protokoll nr 1 om ändring av de protokoll som är fogade till fördraget om Europeiska unionen, fördraget om upprättandet av Europeiska gemenskapen och/eller fördraget om upprättandet av Europeiska atomenergigemenskapen, artikel 1, punkt 12 (gällande protokollet om Europeiska investeringsbankens stadga), led h, lägg till följande led:

| ”iii) | I punkt 4 ska orden ”Inom ramen för fördraget och denna stadga” ersättas med ”Inom ramen för fördragen och denna stadga”.” |
| --- | --- |

”iii)

I punkt 4 ska orden ”Inom ramen för fördraget och denna stadga” ersättas med ”Inom ramen för fördragen och denna stadga”.”

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Child Health and Human Development Special Emphasis Panel, MRDD Center Review.                    

*Date:*                         March 18, 2008.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Renaissance Mayflower Hotel, 1127 Connecticut Avenue, NW., Washington, DC 20036.                    

*Contact Person:*                         Norman Chang, PhD., Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, (301) 496-1485,                         *changn@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS)

Dated: February 14, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-792 Filed 2-21-08; 8:45 am]

BILLING CODE 4140-01-M
Exhibit 32.01

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES OXLEY ACT OF 2002

         In connection with the Annual Report of Westside Energy Corporation
(the "Company") on Form 10 KSB for the period ended December 31, 2003, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that:

         (1)      The Report fully complies with the  requirements  of Section
13(a) or 15(d) of the  Securities  Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

April 13, 2004                   By: /s/ Jimmy D. Wright
                                 -------------------
                                 Jimmy D. Wright
                                 Chief Executive Officer


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                               SECTION 906 OF THE
                           SARBANES OXLEY ACT OF 2002

         In connection with the Annual Report of Westside Energy Corporation
(the "Company") on Form 10 KSB for the period ended December 31, 2003, as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that:

         (1)      The Report fully complies with the  requirements  of Section
13(a) or 15(d) of the  Securities  Exchange Act of 1934; and

         (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

April 13, 2004                   By: /s/ Jimmy D. Wright
                                 -------------------
                                 Jimmy D. Wright
                                 Chief Financial Officer
[No. 938.]

#### JAMES FINLAYSON, Appellant, *v.*WILLIAM A. MONTGOMERY, Respondent.

Appeal must be Prosecuted — Failure to File Bribes. — If appellant’s counsel fail to appear and orally argue the case -when set for trial, and also fail to file any brief within the time allowed by the court, the judgment will be affirmed without any examination of the record on appeal.

Appeal from the District Court of the Sixth Judicial District, Eureka County.

The facts appear in the-opinion.

*398
      *Wren and Thornton,*for Appellant.

*A. M. Hillhouse,*for Respondent.

By the Court,

Leonard, J.:

On the eighteenth day of November, 1878, this case was set down for argument. No oral argument was had, but a stipulation was filed by the parties, agreeing to submit the case upon briefs to be filed. Appellant was given until December 1st, and respondent ten days ther-eafter.

Subsequently other stipulations of counsel were filed, extending the time for filing briefs. On the 3d day of the present month, counsel for appellant, when in court, were granted ten days further time. That time has expired, and still appellant has filed no brief.

Under such circumstances we do not consider it our duty to look into the record. The judgment of the court below is affirmed for appellant’s failure to prosecute the appeal. *(Fulton*v. *Day,*8 Nevada, 82.)
Ohr Pharmaceutical, Inc. 10-K





 


 


Exhibit
10.8(b)


 


FIRST AMENDMENT


TO

OHR PHARMACEUTICAL, INC.


AMENDED AND RESTATED 2014 STOCK INCENTIVE
PLAN


 


 


This First Amendment (this “Amendment”)
is to be effective as of March 31, 2014.


 


1.Section 4(a) of the
Ohr Pharmaceutical, Inc. 2014 Stock Incentive Plan is amended and restated in its entirety as follows:


 


“(a) Number of
Shares Available for Awards. The shares subject to Awards granted under the Plan shall be 2,750,000 Shares. Such Shares subject
to the Plan may be either authorized and unissued Shares (which will not be subject to preemptive rights) or previously issued
Shares acquired by the Company or any Affiliate.


 


2.This Amendment was duly adopted and approved by the Board
of Directors of Ohr Pharmaceutical, Inc. (the “Company”) on January 6, 2015 and by the stockholders of the Company
on March 10, 2015.